Join us for an audio catch-up on the major events in the biopharma industry over the past business week, as reported by Scrip‘s global team, in this podcast version of Five Must-Know Things.
This episode covers insights for the business week ended 11 October 2024, including: making cell and gene therapies more accessible; Roche’s obesity plans; BIOSECURE and Indian firms; IPOs begin to recover; and Nxera looks to the future.
This and all our other podcasts are available on the Citeline channel on Apple Podcasts, Google Podcasts, SoundCloud, TuneIn and Spotify Podcasts, and via smart speakers if one of these platforms has been set up as your default podcast provider.
Stories mentioned in this episode:
Big Pharma Faces Cell And Gene Therapy Market Realities
Roche’s Plan To Muscle In On Obesity
BIOSECURE Act - Which Indian Firms Are Best Placed To Help Plug Pharma’s Sourcing Gaps?
Quarterly IPOs Climb Back Above $1bn
Nxera: Building To Become Japan’s Global Biotech Champion
